Hematopoietic cytokines as tumor markers in gynecological malignancies: A multivariate analysis with ROC curve in endometrial cancer patients

References

• Asschert JGW, Vellenga E, Hollema H, van der Zee AGJ, de Vries EGE. 1997. Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1β(IL-1β), interlekin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas. Eur J Cancer. 33:2246–2251.
   PubMedGoogle Scholar
• Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. 1991. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer. 67:990–996.
   PubMed Web of Science ®Google Scholar
• Baj G, Arnulfo A, Boldorini R, Nicosia G, Villa L, Malavasi F, Surico N. 2000. Hormonal modulation of GM-CSF receptor alpha-chain in in vitro models of endometrial cancer. Eur J Gynaecol Oncol. 21:305–308.
   PubMedGoogle Scholar
• Chao K, Chang C, Yen M, Wang P, Ng H. 1999. Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro. Gynecol Obstet Invest. 48:280–284.
   PubMed Web of Science ®Google Scholar
• Elmore LW, Domson K, Moore JR, Kornstein M, Burks T. 2001. Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch Pathol Lab Med. 125:146–151.
   PubMedGoogle Scholar
• Gadducci A, Cosio S, Capri A, Nicolini A, Genazzani AR. 2004. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother. 58:24–38.
   PubMed Web of Science ®Google Scholar
• Ginath S, Menczer J, Fintsi Y, Ben-Shem E, Glezerman M, Avinoach I. 2002. Tissue and serum CA 125 expression in endometrial cancer. Int J Gynecol Cancer. 12:372–375.
   PubMed Web of Science ®Google Scholar
• Groblewska M, Mroczko B, Wereszczyńska-Siemiętkowska U, Myśliwiec P, Kędra B, Szmitkowski M. 2007. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med. 45:30–34.
   PubMed Web of Science ®Google Scholar
• Hirasawa K, Kitamura T, Oka T, Matsushita H. 2002. Bladder tumor producing granulocyte—colony stimulating factor and parathyroid hormone related protein. J Urol. 167:2130.
   PubMed Web of Science ®Google Scholar
• Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. 1994. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res. 54:3049–3053.
   PubMed Web of Science ®Google Scholar
• Kamińska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M, Steffen J. 2006. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. Oncology. 70:115–125.
   PubMed Web of Science ®Google Scholar
• Kaściński B. 2002. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat Res. 107:285–292.
   PubMedGoogle Scholar
• Ławicki S, Będkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. 2007. The plasma levels and diagnostics utility of stem cell factor and macrophage colony stimulating factor in endometrial cancer patients. Przegl Lek. 64:987–990.
   PubMedGoogle Scholar
• Ławicki S, Będkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. 2009. The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri. Pol Merkur Lekarski. 156:609–615.
   Google Scholar
• Ławicki S, Będkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. 2010. The plasma levels and diagnostics utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri. Pol Merkur Lekarski. 167:354–358.
   Google Scholar
• Ławicki S, Będkowska GE, Gacuta-Szumarska E, Knapp P, Szmitkowski M. 2008. The plasma levels and diagnostics utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients. Pol Merkur Lekarski. 25:38–42.
   PubMedGoogle Scholar
• Ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M. 2006. The plasma levels and diagnostics utility of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in ovarian cancer patients. Pol Merkur Lekarski. 125:465–468.
   Google Scholar
• Ławicki S, Czygier M, Omyła J, Będkowska E, Szmitkowski M. 2007. The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients. Pol Merkur Lekarski. 136:259–262.
   Google Scholar
• Ławicki S, Szmitkowski M, Wojtukiewicz M. 2006. The pretreatment plasma level and diagnostics utility of M-CSF in benign breast and breast cancer patients. Clin Chim Acta. 371:112–116.
   PubMed Web of Science ®Google Scholar
• Lockhart CJ, McVeigh GE, Harbinson MT. 2008. Elevated CA 125 and ascites: Not always malignancy. Ir J Med Sci. 177:63–66.
   PubMedGoogle Scholar
• Mettler L, Salmassi A. 2005. Endometriosis and M-CSF receptor. Eur J Obstet Gynecol Reproduct Biol. 123 Suppl.: S1–S66.
   Google Scholar
• Milojkovic M, Hrgovic Z, Hrgovic I, Jonat W, Maass N, Buković D. 2004. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet. 269:176–180.
   PubMedGoogle Scholar
• Miyasaka N. 2005. Introduction: Cytokine receptors and their classification. Nippon Rinsho. 63 Suppl.: S5–S9.
   PubMedGoogle Scholar
• Mroczko B, Groblewska M, Wereszczyńska-Siemiętkowska U, Kędra B, Konopko M, Szmitkowski M. 2006. The diagnostics value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. Clin Chim Acta. 371:143–147.
   PubMed Web of Science ®Google Scholar
• Mroczko B, Szmitkowski M, Wereszczyńska-Siemiętkowska U, Okulczyk B. 2005. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. Dig Dis Sci. 50:203–209.
   Google Scholar
• Mroczko B, Wereszczyńska-Siemiętkowska U, Groblewska M, Łukaszewicz M, Szmitkowski M, Gryko M, Kedra B. 2006. The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients. Clin Chim Acta. 374:165–167.
   PubMed Web of Science ®Google Scholar
• Nasu K, Inoue C, Takai N, Kashima K, Miyakawa I. 2004. Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor. Obstet Gynecol. 104:1086–1088.
   PubMed Web of Science ®Google Scholar
• Ohike N, Sato M, Hisayuki T, Imataka H, Sato S, Wada Y, Saito K, Takahashi M, Tajiri T, Kunimura T, Morohoshi T. 2007. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors. Pathol Int. 57:589–593.
   PubMed Web of Science ®Google Scholar
• Osuga Y, Koga K, Tsutsumi O, Igarashi T, Okagaki R, Takai Y, De Bruijn HW, Van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr. 2000. Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. Am J Reprod Immunol. 44:231–235.
   PubMed Web of Science ®Google Scholar
• Parker WH. 2007. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 87:725–736.
   PubMed Web of Science ®Google Scholar
• Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J. 1998. Cytokine production profiles in the peritoneal fluids of patients with malignanat or benign gynecologic tumors. Cancer. 83:788–796.
   PubMed Web of Science ®Google Scholar
• Puride DM. 2003. Epidemiology of endometrial cancer. Rev Gynaecol Pract. 3:217–220.
   Google Scholar
• Rony AA, Horowitz IR, Tekmal RR. 1999. Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia. Am J Obstet Gynecol. 180:28–32.
   PubMedGoogle Scholar
• Savarese DM, Valiński H, Quesenberry P, Savarese T. 1998. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate. 34:80–91.
   PubMed Web of Science ®Google Scholar
• Shizmu N, Miyatake R, Esa A. 2005. Squamous cell carcinoma of bladder producing granulocyte colony-stimulating factor (G-CSF): A case report. Acta Urol Jpn. 51:121–124.
   PubMedGoogle Scholar
• Sjovall K, Nilsson B, Einhorn N. 2002. The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol Oncol. 85:175–178.
   PubMed Web of Science ®Google Scholar
• Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr.. 2004. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol. 22:4059–4066.
   PubMed Web of Science ®Google Scholar
• Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. 1995. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res. 1:313–325.
   Google Scholar
• Suzuki M, Ohwada M, Sato L, Nagamoto M. 1995. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology. 52:128–133.
   PubMed Web of Science ®Google Scholar
• Timmerman D, Van den Bosch T. 2005. Diagnostic strategies in endometrial cancer. Int Congress Ser. 1279:141–148.
   Google Scholar
• Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi J-P, Darai E. 2005. Endometrium from women with and without endometriosis, and peritoneal, ovarian and bowel endometriosis, show different c-kit protein expression. J Reprod Immunol. 65:55–63.
   PubMedGoogle Scholar
• Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F. 2011. HE4 and CA 125 as a diagnostic test in ovarian cancer: Prospective validation of the risk of ovarian malignancy algorithm. Br J Cancer. 104:863–870.
   PubMed Web of Science ®Google Scholar